Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
214 participants
OBSERVATIONAL
2017-11-30
2021-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calcinosis in a Single-Center Scleroderma Population
NCT02062125
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Systemic sclerosis patients
Radiography
Radiography of the hand and feet (face incident) the day of the inclusion
Veinous punction
Blood sample to analysis VEGF, endothelin 1, endostatin and P/GF, (ELISA method)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiography
Radiography of the hand and feet (face incident) the day of the inclusion
Veinous punction
Blood sample to analysis VEGF, endothelin 1, endostatin and P/GF, (ELISA method)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Given their consent
* Titulary of health insurance
Exclusion Criteria
* Pregnant or breastfeeding women
* Imprisoned person
* Refuse of consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent SOBANSKI, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Claude Huriez, CHU
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01822-51
Identifier Type: OTHER
Identifier Source: secondary_id
2016_43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.